{"id":"https://openalex.org/W2070110481","doi":"https://doi.org/10.1111/j.2042-7158.1980.tb12933.x","title":"Effects of 3,4-dihydroxyphenylpyruvic acid and L-glutamic acid on some pharmacokinetic parameters of L-dopa in the rat","display_name":"Effects of 3,4-dihydroxyphenylpyruvic acid and L-glutamic acid on some pharmacokinetic parameters of L-dopa in the rat","publication_year":1980,"publication_date":"1980-09-01","ids":{"openalex":"https://openalex.org/W2070110481","doi":"https://doi.org/10.1111/j.2042-7158.1980.tb12933.x","mag":"2070110481","pmid":"https://pubmed.ncbi.nlm.nih.gov/6104700"},"language":"en","primary_location":{"id":"doi:10.1111/j.2042-7158.1980.tb12933.x","doi":"https://doi.org/10.1111/j.2042-7158.1980.tb12933.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.2042-7158.1980.tb12933.x","pdf_url":null,"source":{"id":"https://openalex.org/S118304455","display_name":"Journal of Pharmacy and Pharmacology","issn_l":"0022-3573","issn":["0022-3573","2042-7158"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy and Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111909304","display_name":"Inge\u2010Britt Lind\u00e9n","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Inge-Britt Lind\u00e9n","raw_affiliation_strings":["Research Laboratories of Medica Ltd. , P.O.B. 325, SF-00101 Helsinki 10,","Research Laboratories of Medica Ltd., P.O.B. 325, SF-00101 Helsinki 10, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories of Medica Ltd. , P.O.B. 325, SF-00101 Helsinki 10,","institution_ids":[]},{"raw_affiliation_string":"Research Laboratories of Medica Ltd., P.O.B. 325, SF-00101 Helsinki 10, Finland","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5111909304"],"corresponding_institution_ids":[],"apc_list":{"value":2911,"currency":"GBP","value_usd":3839},"apc_paid":null,"fwci":1.4513,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.7885,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"32","issue":"1","first_page":"344","last_page":"348"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.923799991607666,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.923799991607666,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12770","display_name":"Amino Acid Enzymes and Metabolism","score":0.01940000057220459,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11027","display_name":"Metabolism and Genetic Disorders","score":0.014000000432133675,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/l-dopa","display_name":"L-DOPA","score":0.9520000219345093},{"id":"https://openalex.org/keywords/glutamate","display_name":"glutamate","score":0.9869999885559082},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7889999747276306},{"id":"https://openalex.org/keywords/dopamine","display_name":"dopamine","score":0.5910000205039978},{"id":"https://openalex.org/keywords/3-o-methyldopa","display_name":"3-O-methyldopa","score":0.9070000052452087},{"id":"https://openalex.org/keywords/blood-brain-barrier","display_name":"blood-brain barrier","score":0.8199999928474426},{"id":"https://openalex.org/keywords/transamination","display_name":"transamination","score":0.7160000205039978},{"id":"https://openalex.org/keywords/homovanillic-acid","display_name":"homovanillic acid","score":0.8709999918937683},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.6549999713897705}],"concepts":[{"id":"https://openalex.org/C2775841634","wikidata":"https://www.wikidata.org/wiki/Q903566","display_name":"Homovanillic acid","level":4,"score":0.8323707580566406},{"id":"https://openalex.org/C68793091","wikidata":"https://www.wikidata.org/wiki/Q603891","display_name":"Transamination","level":3,"score":0.7533208131790161},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.7158792614936829},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5882083177566528},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5396113395690918},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5311191082000732},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.5210158824920654},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5084553956985474},{"id":"https://openalex.org/C2778740566","wikidata":"https://www.wikidata.org/wiki/Q181136","display_name":"Glutamic acid","level":3,"score":0.48008495569229126},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.43675506114959717},{"id":"https://openalex.org/C2780304432","wikidata":"https://www.wikidata.org/wiki/Q300989","display_name":"Levodopa","level":4,"score":0.41480231285095215},{"id":"https://openalex.org/C515207424","wikidata":"https://www.wikidata.org/wiki/Q8066","display_name":"Amino acid","level":2,"score":0.3987082242965698},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.36353039741516113},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3263446092605591},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.308711439371109},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.21066829562187195},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.18302851915359497},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.1406000554561615},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.09842845797538757},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001923","descriptor_name":"Brain Chemistry","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005971","descriptor_name":"Glutamates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006719","descriptor_name":"Homovanillic Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007980","descriptor_name":"Levodopa","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007980","descriptor_name":"Levodopa","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008750","descriptor_name":"Methyldopa","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010667","descriptor_name":"Phenylpyruvic Acids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.2042-7158.1980.tb12933.x","doi":"https://doi.org/10.1111/j.2042-7158.1980.tb12933.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.2042-7158.1980.tb12933.x","pdf_url":null,"source":{"id":"https://openalex.org/S118304455","display_name":"Journal of Pharmacy and Pharmacology","issn_l":"0022-3573","issn":["0022-3573","2042-7158"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy and Pharmacology","raw_type":"journal-article"},{"id":"pmid:6104700","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6104700","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of pharmacy and pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W1596685982","https://openalex.org/W1964509965","https://openalex.org/W1976624048","https://openalex.org/W1984917146","https://openalex.org/W1986110792","https://openalex.org/W2023569151","https://openalex.org/W2026087181","https://openalex.org/W2053596442","https://openalex.org/W2139425233","https://openalex.org/W2202180915","https://openalex.org/W2312760460","https://openalex.org/W2326360741"],"related_works":["https://openalex.org/W1986110792","https://openalex.org/W2108874406","https://openalex.org/W1982314773","https://openalex.org/W2312760460","https://openalex.org/W1990763526","https://openalex.org/W2346071831","https://openalex.org/W2078413758","https://openalex.org/W2141088682","https://openalex.org/W2027654524","https://openalex.org/W1984917146"],"abstract_inverted_index":{"In":[0],"the":[1,18,31,52,63,71,80,83,88,104,113,117,126],"rat,":[2],"various":[3],"oral":[4,37],"doses":[5,40],"of":[6,41,57,82,93,120,128,136],"3,4-dihydroxyphenylpyruvic":[7],"acid":[8,97,110],"(DHPPA)":[9],"administered":[10],"simultaneously":[11],"with":[12],"L-dopa":[13,20,29,50,84,94,101,121,129,137],"were":[14,60],"shown":[15],"to":[16,49,86],"elevate":[17],"serum":[19,72,105],"and":[21,38,95,106,108,138],"cerebral":[22],"dopamine":[23,58],"concentrations":[24],"dose-dependently.":[25],"With":[26],"increasing":[27],"DHPPA:":[28],"ratio":[30],"L-dopa-sparing":[32],"effect":[33],"became":[34],"greater.":[35],"Although":[36],"intravenous":[39],"DHPPA":[42,74],"showed":[43],"that":[44,125],"it":[45],"was":[46],"readily":[47],"converted":[48],"in":[51,62,70,103,112,143],"serum,":[53],"only":[54],"small":[55],"amounts":[56],"(DA)":[59],"detected":[61],"brain.":[64],"The":[65],"high":[66],"3-O-methyldopa":[67],"concentrations,":[68],"measured":[69],"after":[73],"administration,":[75],"might":[76],"be":[77,132],"responsible":[78],"for":[79],"failure":[81],"formed":[85],"pass":[87],"blood-brain":[89],"barrier.":[90],"Concomitant":[91],"administration":[92],"glutamic":[96],"gave":[98],"significantly":[99],"higher":[100],"values":[102,111],"DA":[107],"homovanillic":[109],"brain":[114],"than":[115],"did":[116],"same":[118],"dose":[119],"alone.":[122],"This":[123],"indicates":[124],"transamination":[127],"can":[130],"also":[131],"effected":[133],"by":[134],"coadministration":[135],"an":[139],"amino":[140],"group":[141],"donor":[142],"vivo.":[144]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}